TY  - GEN
AU  - Gomez-Veiga,F
AU  - Ponce-Reixa,J
AU  - Martinez-Breijo,S
AU  - Planas,J
AU  - Morote,J
TI  - Advances in prevention and treatment of bone metastases in prostate cancer. Role of RANK/RANKL inhibition
SN  - 1699-7980
PY  - 2014///0801
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Antibodies, Monoclonal, Humanized
KW  - pharmacology
KW  - Antineoplastic Agents
KW  - Bone Density Conservation Agents
KW  - Bone Neoplasms
KW  - complications
KW  - Clinical Trials, Phase III as Topic
KW  - Denosumab
KW  - Diphosphonates
KW  - Double-Blind Method
KW  - Forecasting
KW  - Fractures, Spontaneous
KW  - etiology
KW  - Humans
KW  - Imidazoles
KW  - Male
KW  - Models, Biological
KW  - Molecular Targeted Therapy
KW  - Multicenter Studies as Topic
KW  - Neoplasm Proteins
KW  - antagonists & inhibitors
KW  - Practice Guidelines as Topic
KW  - Prostatic Neoplasms
KW  - pathology
KW  - Quality of Life
KW  - RANK Ligand
KW  - Randomized Controlled Trials as Topic
KW  - Receptor Activator of Nuclear Factor-kappa B
KW  - physiology
KW  - Zoledronic Acid
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.1016/j.acuro.2012.09.001
ER  -